Unknown

Dataset Information

0

TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma.


ABSTRACT: BACKGROUND:Myeloma bone disease (MBD) can cause bone destruction and increase the level of Ca2+ concentration in the bone marrow microenvironment by stimulating osteoclastic differentiation. Nevertheless, the relationships between MBD and highly efficient stimuli of Ca2+ in multiple myeloma (MM) progression, and possible regulatory mechanisms are poorly defined. Here, we reported that the nonselective cation channel transient receptor potential vanilloid 2 (TRPV2) plays a functional role in Ca2+ oscillations and osteoclastogenesis. METHODS:To investigate the expression of TRPV2 in MM, we analyzed publicly available MM data sets and performed immunohistochemistry in MM patients. The correlations between TRPV2 expression levels and osteoclast-related cytokines were analyzed. Fluo-4 staining and ELISA assays were used to assess the regulated function of TRPV2 in intracellular Ca2+ and cytokines. Western blotting and Chromatin immunoprecipitation (ChIP) assays were performed to explore the signaling pathway of TRPV2-induced osteoclastic differentiation. Real-time PCR, Western blotting, ELISA and tartrate-resistant acid phosphatase (TRAP) staining were performed to detect the biological effects of TRPV2 inhibitor on osteoclastogenesis. RESULTS:The functional expression of TRPV2, involved in the osteolysis through gating the calcium influx, was changed in the MM cells cultured in a high Ca2+ environment. Mechanistically, TRPV2 modulates nuclear factor-?B ligand (RANKL)-dependent osteoclastic differentiation through the Ca2+-calcineurin-NFAT signaling pathway. Of clinical relevance, systemic administration with SKF96365 could attenuate the MM-induced osteoclast formation in vitro. CONCLUSIONS:Our study uncovers the possible roles of TRPV2, which enhances MBD, suggesting that targeting osteocyte-MM cells interactions through blockade of TRPV2 channel may provide a promising treatment strategy in MM.

SUBMITTER: Bai H 

PROVIDER: S-EPMC6191893 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

TRPV2-induced Ca<sup>2+</sup>-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma.

Bai Hua H   Zhu Huayuan H   Yan Qing Q   Shen Xuxing X   Lu Xiupan X   Wang Juejin J   Li Jianyong J   Chen Lijuan L  

Cell communication and signaling : CCS 20181016 1


<h4>Background</h4>Myeloma bone disease (MBD) can cause bone destruction and increase the level of Ca<sup>2+</sup> concentration in the bone marrow microenvironment by stimulating osteoclastic differentiation. Nevertheless, the relationships between MBD and highly efficient stimuli of Ca<sup>2+</sup> in multiple myeloma (MM) progression, and possible regulatory mechanisms are poorly defined. Here, we reported that the nonselective cation channel transient receptor potential vanilloid 2 (TRPV2) p  ...[more]

Similar Datasets

| S-EPMC9741641 | biostudies-literature
| S-EPMC8563877 | biostudies-literature
| S-EPMC4537049 | biostudies-literature
| S-EPMC3630833 | biostudies-other
| S-EPMC8179313 | biostudies-literature
| S-EPMC2765687 | biostudies-literature
| S-EPMC6123628 | biostudies-literature
2022-08-24 | GSE199189 | GEO
| S-EPMC9479617 | biostudies-literature
| S-EPMC5508075 | biostudies-literature